Correction to: A Semi-Physiologically Based Pharmacokinetic Model Describing the Altered Metabolism of Midazolam Due to Inflammation in Mice

Ninad Varkhede; Nita Patel; William Chang; Kenneth Ruterbories; M Laird Forrest

doi:10.1007/s11095-018-2463-9

Correction to: A Semi-Physiologically Based Pharmacokinetic Model Describing the Altered Metabolism of Midazolam Due to Inflammation in Mice

Pharm Res. 2018 Jul 25;35(9):180. doi: 10.1007/s11095-018-2463-9.

Authors

Ninad Varkhede¹, Nita Patel², William Chang³, Kenneth Ruterbories⁴, M Laird Forrest⁵

Affiliations

¹ Department of Pharmaceutical Chemistry, The University of Kansas, 2095 Constant Ave, Lawrence, Kansas, 66047, USA.
² Drug Disposition, Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, 46285, USA.
³ Lilly Biotechnology, Eli Lilly and Company, San Diego, California, 92121, USA.
⁴ Bioanalysis and Biotransformation, Research and Development, AbbVie, North Chicago, Illinois, USA.
⁵ Department of Pharmaceutical Chemistry, The University of Kansas, 2095 Constant Ave, Lawrence, Kansas, 66047, USA. [email protected].

PMID: 30046910
DOI: 10.1007/s11095-018-2463-9

Abstract

One of the authors has his name incorrectly indexed in PubMed and SpringerLink as "Laird Forrest M" (last name "Laird Forrest"). His name should index as "Forrest M. Laird" with last name as "Forrest".

Publication types

Published Erratum

Grants and funding

R01 CA173292/CA/NCI NIH HHS/United States